Skip to main content
Veterinary Medicines

Porcilis PRRS liofilizatas ir skiediklis injekcinei suspensijai ruošti kiaulėms

Not authorised
  • Porcine reproductive and respiratory syndrome virus, type 1, strain DV, Live

Product identification

Medicine name:
Porcilis PRRS liofilizatas ir skiediklis injekcinei suspensijai ruošti kiaulėms
Active substance:
  • Porcine reproductive and respiratory syndrome virus, type 1, strain DV, Live
Target species:
  • Pig
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Porcine reproductive and respiratory syndrome virus, type 1, strain DV, Live
    1995260.00
    tissue culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AD03
Authorisation status:
  • Surrendered
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/02/1385/001-008
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 12/04/2023

RV1385.pdf

Lithuanian (PDF)
Published on: 28/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."